Abstract
Identification of potential druggable targets utilizing protein-protein interactions network (PPIN) has been emerging as a hotspot in drug discovery and development research. However, it remains unclear whether the currently used PPIN topological properties are enough to discriminate the drug targets from non-drug targets. In this study, three-step classification models using different network topological properties were designed and implemented using support vector machine (SVM) to compare the enrichment of known drug targets from non-targets. Surprisingly, none of the models was able to identify more than 75% of the true targets in the test set. It appears that the currently used simple PPIN topological properties are not likely robust enough for prediction of potential drug targets with high confidence, which also echoes similarly unsatisfying prediction data reported previously. However, we proposed that quality and quantity improvement of the protein-protein interactions (PPI) data for model training will help increasing the prediction accuracy.
Keywords: Drug targets, protein-protein interactions network, support vector machine, network topological properties.
Combinatorial Chemistry & High Throughput Screening
Title:Are Topological Properties of Drug Targets Based on Protein-Protein Interaction Network Ready to Predict Potential Drug Targets?
Volume: 19 Issue: 2
Author(s): Shiliang Li, Xiaojuan Yu, Chuanxin Zou, Jiayu Gong and Xiaofeng Liu
Affiliation:
Keywords: Drug targets, protein-protein interactions network, support vector machine, network topological properties.
Abstract: Identification of potential druggable targets utilizing protein-protein interactions network (PPIN) has been emerging as a hotspot in drug discovery and development research. However, it remains unclear whether the currently used PPIN topological properties are enough to discriminate the drug targets from non-drug targets. In this study, three-step classification models using different network topological properties were designed and implemented using support vector machine (SVM) to compare the enrichment of known drug targets from non-targets. Surprisingly, none of the models was able to identify more than 75% of the true targets in the test set. It appears that the currently used simple PPIN topological properties are not likely robust enough for prediction of potential drug targets with high confidence, which also echoes similarly unsatisfying prediction data reported previously. However, we proposed that quality and quantity improvement of the protein-protein interactions (PPI) data for model training will help increasing the prediction accuracy.
Export Options
About this article
Cite this article as:
Li Shiliang, Yu Xiaojuan, Zou Chuanxin, Gong Jiayu and Liu Xiaofeng, Are Topological Properties of Drug Targets Based on Protein-Protein Interaction Network Ready to Predict Potential Drug Targets?, Combinatorial Chemistry & High Throughput Screening 2016; 19 (2) . https://dx.doi.org/10.2174/1386207319666151110122145
DOI https://dx.doi.org/10.2174/1386207319666151110122145 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacogenetic Polymorphisms in a Portuguese Gypsy Population
Current Pharmacogenomics and Personalized Medicine Antiulcer and Antioxidant Activity of a Lectin from Mucuna pruriens Seeds on Ethanol- induced Gastropathy: Involvement of Alpha-2 Adrenoceptors and Prostaglandins
Current Pharmaceutical Design Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders
Current Drug Safety Helicobacter pylori: An Overview on Antimicrobials and Drug Delivery Systems for its Eradication
Current Drug Delivery Subject Index to Volume 10
Current Pharmaceutical Design Scorpion Toxin Polyptides as Therapeutic Agents: An Overview
Protein & Peptide Letters Systemic Inflammation, Infection, ApoE Alleles, and Alzheimer Disease: A Position Paper
Current Alzheimer Research Novel Carriers for Coenzyme Q10 Delivery
Current Drug Delivery Kawasakis Disease, Acrodynia, and Mercury
Current Medicinal Chemistry Harnessing the Prevention Benefits of Antiretroviral Therapy to Address HIV and Tuberculosis
Current HIV Research The Role of Co-Infections in Mother-to-Child Transmission of HIV
Current HIV Research P2X7 Receptors: Channels, Pores and More
CNS & Neurological Disorders - Drug Targets Deciphering Role of Cytokines for Therapeutic Strategies Against Rheumatoid Arthritis
Current Drug Targets The Widespread Anti-Protozoal Action of HIV Aspartic Peptidase Inhibitors: Focus on Plasmodium spp., Leishmania spp. and Trypanosoma cruzi
Current Topics in Medicinal Chemistry Potential Role of TRP Channels in Cough Hypersensitivity?
Current Respiratory Medicine Reviews Micronutrients at the Interface Between Inflammation and Infection Ascorbic Acid and Calciferol. Part 2: Calciferol and the Significance of Nutrient Supplements
Inflammation & Allergy - Drug Targets (Discontinued) The Coronin Family and Human Disease
Current Protein & Peptide Science New Antimicrobial Approaches: Reuse of Old Drugs
Current Drug Targets Importance of Pharmacology Knowledge by Dieticians
Current Nutrition & Food Science Peptide Biomarkers: Exploring the Diagnostic Aspect
Current Protein & Peptide Science